Enabling CDMO Success Through Intelligent Testing Capabilities

Contract design and manufacturing organizations (CDMOs) play an increasingly crucial role in the pharmaceutical supply chain, providing the necessary capabilities and capacity to meet growing patient demand. The recent emergence of GLP-1 class drugs only emphasizes the importance of CDMOs, which con- tribute significant expertise related to fill-finish operations, secondary packaging, and distribution.